InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,699.94
(
-0.17%
)
US TECH 100
19,258.40
(
-0.10%
)
Dow Jones
42,011.59
(
-0.44%
)
Brent Oil
77.53
(
-0.36%
)
Bitcoin
61,243.47
(
0.81%
)
Post# of 23619
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ehihub

Send PM Follow Ignore
Followers 29
Posts 1568
Boards Moderated 0
Alias Born 01/29/2011

ehihub

Re: None

Friday, 04/12/2019 10:55:44 AM

Friday, April 12, 2019 10:55:44 AM

Post# of 23619
From the 9/21/2018 PR:
“These development programs are part of Vilacto Bio’s LACTOACTIVE iTHER® plan to form strategic partnerships with other biotech firms and become the “go-to” partner for enhancing new immunotherapy and vaccine solutions with its refined-colostrum compound “weaponized” as a nanomedicine.”

PARTNERSHIPS.

Like I’ve said before; An announcement can drop at anytime. This company’s PR history is to announce SOLID news. No fluff PRs with VIBI.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up